Evaluation of Fe Absorption From Iron Salt in Milk

Healthy Clinical Trial

Official title:

Evaluation of Iron Absorption From Ferric Ammonium Phosphate and Ferric Pyrophosphate From an Instant Milk Drink in Young Children

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05642689
• Other study ID #: 09.07NRC
• Status: Completed
• Phase: N/A
• Start date: November 2009
• Est. completion date: March 2010

Study information

• Verified date: November 2022
• Source: Nestlé
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The primary objective was: - to compare iron absorption in apparently healthy children aged 3-6y from an instant full cream milk drink fortified with ferric pyrophosphate or ferric ammonium phosphate relative to ferrous sulfate as the reference fortificant. - To compare iron absorption from ferric pyrophosphate to ferric ammonium phosphate from the milk drink

Recruitment information / eligibility

• Status: Completed
• Enrollment: 40
• Est. completion date: March 2010
• Est. primary completion date: January 2010
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 3 Years to 6 Years

Eligibility

Inclusion Criteria:

• 3-6 years old (inclusive)
• Normal BMI for age (WHO standard)
• Apparently healthy, no metabolic or gastrointestinal disorder
• Non-anemic (WHO cut-off for respective age
• No medication or vitamin/mineral supplements will be consumed during the study
• Intake of Vitamin/mineral supplements will be discontinued 2 weeks before the start of the study
• Parents demonstrate an understanding of the given information and ability to comply with the study procedure
• Having obtained his/her parents or his/her legal representative's informed consent

Exclusion Criteria:

• With known gastrointestinal or metabolic disorder or experiencing significant blood losses over the past 6 months
• Possible to have medication during the study
• Currently participating or having participated another clinical trial during the past 3 months prior the beginning of this study
• Subject who cannot be expected to comply with treatment

Related Conditions & MeSH terms

• Healthy

Intervention

Other:
• Iron fortified milk with iron salt labelled with 58Fe and 57Fe
Oral administration of a serving of iron labelled with stable isotope (2 mg Fe per serving) in 200ml of reconstituted milk once after a overnight fast. The alternate test drink was fed on the following day in the same fashion. The administration was repeated on day 3 and 4.
• Iron fortified milk with iron salt labelled with 58Fe and 57Fe
Oral administration of a serving of iron labelled with stable isotope (2 mg Fe per serving) in 200ml of reconstituted milk once after a overnight fast. The alternate test drink was fed on the following day in the same fashion. The administration was repeated on day 3 and 4.

Locations

Country	Name	City	State
n/a

Sponsors (3)

Lead Sponsor	Collaborator
Nestlé	ETH Zurich (Switzerland), Food and Nutrition Research Institute, Philippines

References & Publications (1)

Walczyk T, Kastenmayer P, Storcksdieck Genannt Bonsmann S, Zeder C, Grathwohl D, Hurrell RF. Ferrous ammonium phosphate (FeNH(4)PO(4)) as a new food fortificant: iron bioavailability compared to ferrous sulfate and ferric pyrophosphate from an instant milk drink. Eur J Nutr. 2013 Jun;52(4):1361-8. doi: 10.1007/s00394-012-0445-y. Epub 2012 Sep 6. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Determination of iron absorption from FAP and from ferric pyrophosphate relative to Ferrous sulfate	It is based on calculated amount of 58Fe and 57Fe appearing in the blood. For that the shift of the iron isotope ratios in the blood samples collected 14 days after the last consumption of the last test drink are measured. The calculation of circulating iron is based on blood volume and hemoglobin concentration. For calculations of fractional absorption, 90% incorporation of the absorbed iron into red blood cells is assumed. The relative iron absorption from FAP and from ferric pyrophosphate relative to ferrous sulfate is then calculated as follows: Relative bioavailability of a salt (RBV %) = ( Fe absorption from an iron salt/ Fe absorption from ferrous sulfate)* 100. The comparison of the iron absorption from ferric pyrophosphate to that from ferric ammonium phosphate will be made by statistical analysis of data measured and calculated as described above.	14 days post isotope consumption